AbbVie pitches fifth takeover bid for Shire

Shire (SHPG) says it has received a new $53B takeover proposal from AbbVie (ABBV) and it is willing to recommend the new offer to shareholders.

At £53.20 per Shire share, the new bid includes £24.44 in cash and 0.8960 shares of new AbbVie shares.

The updated deal will result in Shire investors owning approximately 25% of the combined company.

From other sites
Comments (2)
  • DGI_Dan
    , contributor
    Comments (88) | Send Message
    Looks like this deal may actually happen. This will be good for ABBV, but they might by overpaying to perform tax inversion.
    14 Jul 2014, 10:14 AM Reply Like
  • Benyas
    , contributor
    Comments (84) | Send Message
    I find the idea of American companies moving overseas to avoid American taxes sad and annoying. For a major pharmaceutical company to do this is just galling because they derive so much of their income from government programs that pay huge sums for citizens to use their products. That is not to mention the help they get from government funded research that contributes to the development of their products.


    Our taxpayer supported healthcare programs are not able to haggle over the prices charged by the drug companies. Perhaps that policy should change. Maybe it should only change for companies that move out of the country.


    I own Abbvie shares and I admire the company. I do not like the idea that Ireland will require that the transaction is an actual sale of the Abbvie stock that I own. I will then be required to pay a significant capital gain tax.
    I know this because it is what happened when Eaton Corp. merged with an Irish company. I have tried to discuss these issues with my senator Maybe others will do the same.
    14 Jul 2014, 09:51 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs